Theseus Pharmaceuticals, Inc.
Related Filers (36)
- ORBIMED ADVISORS LLC (13)
- GORDON CARL L (10)
- Foresite Capital Fund V, L.P. (8)
- Dahms Bradford D. (7)
- OrbiMed Genesis GP LLC (7)
- OrbiMed Capital GP VII LLC (7)
- CLACKSON TIMOTHY P (6)
- Shakespeare William (6)
- HAYDEN DONALD J JR (5)
- Dukes Iain D. (5)
- Yi Kathy (5)
- FMR LLC (5)
- Rivera Victor (4)
- Kerstein David (4)
- Stein Steven H (4)
- TANG CAPITAL PARTNERS LP (4)
- Concentra Merger Sub II, Inc. (4)
- Foresite Capital Opportunity Management V, LLC (3)
- Tananbaum James B. (3)
- Foresite Capital Opportunity Fund V, L.P. (3)
- Foresite Capital Management V, LLC (3)
- Omega Fund VI, L.P. (2)
- Omega Fund VI GP Manager, Ltd. (2)
- Rock Springs Capital Management LP (2)
- Paster Anne-Mari (2)
- Stampacchia Otello (2)
- Nessi Claudio (2)
- Rock Springs Capital LLC (2)
- Rock Springs Capital Master Fund LP (2)
- ARIAD PHARMACEUTICALS INC (2)
- TAKEDA PHARMACEUTICAL CO LTD (2)
- Dalgarno David (2)
- Frazier Life Sciences Public Fund, L.P. (2)
- Omega Fund VI GP, L.P. (1)
- Rome Michael E (1)
- Nasdaq Stock Market LLC (1)
- Show More ...
Financials (10)
10-Q
Friday, 11/17/2023
Quarterly Report for period ending 2023-09-30
NT 10-Q
Wednesday, 11/15/2023
Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending 2023-09-30
10-Q
Thursday, 8/10/2023
Quarterly Report for period ending 2023-06-30
10-Q
Thursday, 5/11/2023
Quarterly Report for period ending 2023-03-31
10-K
Thursday, 3/9/2023
Annual Report for period ending 2022-12-31
10-Q
Thursday, 11/3/2022
Quarterly Report for period ending 2022-09-30
10-Q
Thursday, 8/11/2022
Quarterly Report for period ending 2022-06-30
10-Q
Thursday, 5/12/2022
Quarterly Report for period ending 2022-03-31
10-K
Thursday, 3/10/2022
Annual Report for period ending 2021-12-31
10-Q
Monday, 11/15/2021
Quarterly Report for period ending 2021-09-30
News (23)
8-K
Wednesday, 2/14/2024
Current report filing
8-K
Friday, 12/22/2023
Current report filing
8-K
Monday, 12/4/2023
Current report filing
8-K
Monday, 11/27/2023
Current report filing
8-K
Monday, 11/13/2023
Current report filing
8-K
Tuesday, 10/31/2023
Current report filing
8-K
Thursday, 8/10/2023
Current report filing
8-K
Thursday, 7/13/2023
Current report filing
8-K
Friday, 6/9/2023
Current report filing
8-K
Thursday, 5/25/2023
Current report filing
8-K
Thursday, 5/11/2023
Current report filing
8-K
Thursday, 3/9/2023
Current report filing
8-K
Thursday, 1/5/2023
Current report filing
8-K
Thursday, 11/3/2022
Current report filing
8-K
Wednesday, 10/19/2022
Current report filing
8-K
Thursday, 8/11/2022
Current report filing
8-K
Monday, 6/13/2022
Current report filing
8-K
Wednesday, 5/18/2022
Current report filing
8-K
Thursday, 5/12/2022
Current report filing
8-K
Thursday, 3/10/2022
Current report filing
8-K
Monday, 1/10/2022
Current report filing
8-K
Monday, 11/15/2021
Current report filing
8-K
Wednesday, 10/27/2021
Current report filing
Other (21)
EFFECT
Thursday, 2/15/2024
Notice of Effectiveness
25-NSE
Wednesday, 2/14/2024
Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
SC 14D9/A
Wednesday, 2/14/2024
Tender offer solicitation/recommendation statements filed under Rule 14d-9
POS AM
Wednesday, 2/14/2024
Post-effective amendment to a registration statement that is not immediately effective upon filing
SC 14D9/A
Wednesday, 2/7/2024
Tender offer solicitation/recommendation statements filed under Rule 14d-9
SC 14D9/A
Tuesday, 1/30/2024
Tender offer solicitation/recommendation statements filed under Rule 14d-9
SC 14D9
Wednesday, 1/10/2024
Tender offer solicitation/recommendation statements filed under Rule 14d-9
SC14D9C
Friday, 12/22/2023
Written communication by the subject company relating to a third party tender offer
ARS
Wednesday, 4/26/2023
Annual report to security holders
EFFECT
Thursday, 11/10/2022
Notice of Effectiveness
CORRESP
Tuesday, 11/8/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
SEC STAFF LETTER
Wednesday, 10/6/2021
None
CERT
Wednesday, 10/6/2021
Certification by an exchange approving securities for listing
EFFECT
Wednesday, 10/6/2021
Notice of Effectiveness
CORRESP
Monday, 10/4/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Monday, 10/4/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
8-A12B
Friday, 10/1/2021
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
SEC STAFF LETTER
Monday, 8/30/2021
None
D/A
Thursday, 2/4/2021
Exempt (Private) Offering
D
Thursday, 2/4/2021
Exempt (Private) Offering
D
Friday, 6/29/2018
Exempt (Private) Offering
Ownership (97)
SC 13D/A
Friday, 2/16/2024
TANG CAPITAL PARTNERS LP: Major Shareholders
4
Wednesday, 2/14/2024
Stein Steven H: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/14/2024
Yi Kathy: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/14/2024
HAYDEN DONALD J JR: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/14/2024
Dahms Bradford D.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/14/2024
ORBIMED ADVISORS LLC: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/14/2024
Dukes Iain D.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/14/2024
GORDON CARL L: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 2/13/2024
Frazier Life Sciences Public Fund, L.P.: Major Shareholders
SC 13D/A
Friday, 1/12/2024
TANG CAPITAL PARTNERS LP: Major Shareholders
SC 13D/A
Thursday, 12/28/2023
TANG CAPITAL PARTNERS LP: Major Shareholders
SC 13D/A
Wednesday, 12/27/2023
ORBIMED ADVISORS LLC: Major Shareholders
SC 13D
Friday, 11/24/2023
TANG CAPITAL PARTNERS LP: Major Shareholders
SC 13D/A
Friday, 11/24/2023
ORBIMED ADVISORS LLC: Major Shareholders
SC 13D/A
Friday, 11/24/2023
Foresite Capital Fund V, L.P.: Major Shareholders
4
Tuesday, 11/7/2023
Shakespeare William: Statement of changes in beneficial ownership of securities
SC 13G/A
Thursday, 8/10/2023
FMR LLC: Major Shareholders
4
Wednesday, 7/19/2023
ORBIMED ADVISORS LLC: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/19/2023
Tananbaum James B.: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 7/19/2023
Foresite Capital Fund V, L.P.: Major Shareholders
4
Wednesday, 7/19/2023
GORDON CARL L: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 7/19/2023
ORBIMED ADVISORS LLC: Major Shareholders
4
Tuesday, 6/13/2023
Stein Steven H: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/13/2023
Yi Kathy: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/13/2023
GORDON CARL L: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/13/2023
Dukes Iain D.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/13/2023
HAYDEN DONALD J JR: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 3/14/2023
ORBIMED ADVISORS LLC: Major Shareholders
4
Thursday, 3/2/2023
Shakespeare William: Statement of changes in beneficial ownership of securities
4
Thursday, 3/2/2023
Rivera Victor: Statement of changes in beneficial ownership of securities
4
Thursday, 3/2/2023
Dahms Bradford D.: Statement of changes in beneficial ownership of securities
4
Thursday, 3/2/2023
CLACKSON TIMOTHY P: Statement of changes in beneficial ownership of securities
4
Thursday, 3/2/2023
Kerstein David: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/21/2023
Rivera Victor: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/21/2023
Dahms Bradford D.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/21/2023
Kerstein David: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/21/2023
CLACKSON TIMOTHY P: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/21/2023
Shakespeare William: Statement of changes in beneficial ownership of securities
SC 13G/A
Thursday, 2/9/2023
FMR LLC: Major Shareholders
SC 13G
Monday, 1/23/2023
Frazier Life Sciences Public Fund, L.P.: Major Shareholders
4
Tuesday, 1/3/2023
HAYDEN DONALD J JR: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/3/2023
Tananbaum James B.: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 1/3/2023
Foresite Capital Fund V, L.P.: Major Shareholders
SC 13G/A
Monday, 12/12/2022
FMR LLC: Major Shareholders
4
Thursday, 12/1/2022
Dahms Bradford D.: Statement of changes in beneficial ownership of securities
4
Monday, 11/14/2022
CLACKSON TIMOTHY P: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/9/2022
GORDON CARL L: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/9/2022
ORBIMED ADVISORS LLC: Statement of changes in beneficial ownership of securities
3
Wednesday, 10/19/2022
Stein Steven H: Initial statement of beneficial ownership of securities
4
Wednesday, 10/19/2022
Stein Steven H: Statement of changes in beneficial ownership of securities
4
Monday, 6/13/2022
Dukes Iain D.: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 6/13/2022
Foresite Capital Fund V, L.P.: Major Shareholders
4
Monday, 6/13/2022
Yi Kathy: Statement of changes in beneficial ownership of securities
4
Monday, 6/13/2022
GORDON CARL L: Statement of changes in beneficial ownership of securities
3
Monday, 6/13/2022
Tananbaum James B.: Initial statement of beneficial ownership of securities
3
Wednesday, 5/18/2022
HAYDEN DONALD J JR: Initial statement of beneficial ownership of securities
4
Wednesday, 5/18/2022
HAYDEN DONALD J JR: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/23/2022
Dalgarno David: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/23/2022
Rivera Victor: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/23/2022
Shakespeare William: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/23/2022
Kerstein David: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/23/2022
CLACKSON TIMOTHY P: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/23/2022
Dahms Bradford D.: Statement of changes in beneficial ownership of securities
SC 13G/A
Wednesday, 2/9/2022
FMR LLC: Major Shareholders
4
Friday, 1/21/2022
ORBIMED ADVISORS LLC: Statement of changes in beneficial ownership of securities
4
Friday, 1/21/2022
GORDON CARL L: Statement of changes in beneficial ownership of securities
4
Thursday, 1/13/2022
ORBIMED ADVISORS LLC: Statement of changes in beneficial ownership of securities
4
Thursday, 1/13/2022
GORDON CARL L: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/22/2021
CLACKSON TIMOTHY P: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/22/2021
Dahms Bradford D.: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 11/18/2021
ORBIMED ADVISORS LLC: Major Shareholders
SC 13G
Wednesday, 11/10/2021
FMR LLC: Major Shareholders
SC 13D
Tuesday, 10/19/2021
ORBIMED ADVISORS LLC: Major Shareholders
SC 13D
Monday, 10/18/2021
Foresite Capital Fund V, L.P.: Major Shareholders
4
Friday, 10/15/2021
ARIAD PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
3
Friday, 10/15/2021
ARIAD PHARMACEUTICALS INC: Initial statement of beneficial ownership of securities
4
Thursday, 10/14/2021
Stampacchia Otello: Statement of changes in beneficial ownership of securities
4
Thursday, 10/14/2021
Rock Springs Capital Management LP: Statement of changes in beneficial ownership of securities
4
Thursday, 10/14/2021
ORBIMED ADVISORS LLC: Statement of changes in beneficial ownership of securities
4
Thursday, 10/14/2021
GORDON CARL L: Statement of changes in beneficial ownership of securities
4
Thursday, 10/14/2021
Shakespeare William: Statement of changes in beneficial ownership of securities
4
Friday, 10/8/2021
GORDON CARL L: Statement of changes in beneficial ownership of securities
4
Friday, 10/8/2021
Dukes Iain D.: Statement of changes in beneficial ownership of securities
4
Friday, 10/8/2021
Yi Kathy: Statement of changes in beneficial ownership of securities
3
Wednesday, 10/6/2021
Rock Springs Capital Management LP: Initial statement of beneficial ownership of securities
3
Wednesday, 10/6/2021
Rivera Victor: Initial statement of beneficial ownership of securities
3
Wednesday, 10/6/2021
ORBIMED ADVISORS LLC: Initial statement of beneficial ownership of securities
3
Wednesday, 10/6/2021
Rome Michael E: Initial statement of beneficial ownership of securities
3
Wednesday, 10/6/2021
Shakespeare William: Initial statement of beneficial ownership of securities
3
Wednesday, 10/6/2021
Dahms Bradford D.: Initial statement of beneficial ownership of securities
3
Wednesday, 10/6/2021
Kerstein David: Initial statement of beneficial ownership of securities
3
Wednesday, 10/6/2021
Dukes Iain D.: Initial statement of beneficial ownership of securities
3
Wednesday, 10/6/2021
GORDON CARL L: Initial statement of beneficial ownership of securities
3
Wednesday, 10/6/2021
Stampacchia Otello: Initial statement of beneficial ownership of securities
3
Wednesday, 10/6/2021
Dalgarno David: Initial statement of beneficial ownership of securities
3
Wednesday, 10/6/2021
Yi Kathy: Initial statement of beneficial ownership of securities
3
Wednesday, 10/6/2021
CLACKSON TIMOTHY P: Initial statement of beneficial ownership of securities
Prospectus (16)
SC TO-T/A
Wednesday, 2/14/2024
Third party tender offer statement
S-8 POS
Wednesday, 2/14/2024
Post-effective amendment to a S-8 registration statement
S-8 POS
Wednesday, 2/14/2024
Post-effective amendment to a S-8 registration statement
SC TO-T/A
Wednesday, 2/7/2024
Third party tender offer statement
SC TO-T/A
Tuesday, 1/30/2024
Third party tender offer statement
SC TO-T
Tuesday, 1/9/2024
Third party tender offer statement
S-8
Thursday, 3/9/2023
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-3
Thursday, 11/3/2022
Registration statement for specified transactions by certain issuers
S-8
Friday, 10/8/2021
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B4
Thursday, 10/7/2021
Prospectus filed pursuant to Rule 424(b)(4)
S-1MEF
Wednesday, 10/6/2021
A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S-1
S-1/A
Thursday, 9/30/2021
General form of registration statement for all companies including face-amount certificate companies
S-1
Wednesday, 9/15/2021
General form of registration statement for all companies including face-amount certificate companies
DRSLTR
Monday, 8/23/2021
Correspondence Related to Draft Registration Statement
DRS/A
Monday, 8/23/2021
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRS
Tuesday, 7/20/2021
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Proxies (5)
DEF 14A
Wednesday, 4/26/2023
Definitive proxy statements
DEFA14A
Wednesday, 4/26/2023
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
PRE 14A
Friday, 4/14/2023
Preliminary proxy statement not related to a contested matter or merger/acquisition
DEFA14A
Monday, 4/25/2022
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Monday, 4/25/2022
Definitive proxy statements